Literature DB >> 20153900

Vitamin E and age-related macular degeneration in a randomized trial of women.

William G Christen1, Robert J Glynn, Emily Y Chew, Julie E Buring.   

Abstract

OBJECTIVE: To test whether alternate day vitamin E affects the incidence of age-related macular degeneration (AMD) in a large-scale randomized trial of women.
DESIGN: Randomized, double-masked, placebo-controlled trial. PARTICIPANTS: Thirty-nine thousand eight hundred seventy-six apparently healthy female health professionals aged 45 years or older. INTERVENTION: Participants were assigned randomly to receive either 600 IU of natural-source vitamin E on alternate days or placebo. MAIN OUTCOME MEASURES: Incident AMD responsible for a reduction in best-corrected visual acuity to 20/30 or worse based on self-report confirmed by medical record review.
RESULTS: After 10 years of treatment and follow-up, there were 117 cases of AMD in the vitamin E group and 128 cases in the placebo group (relative risk, 0.93; 95% confidence interval, 0.72-1.19).
CONCLUSIONS: In a large-scale randomized trial of female health professionals, long-term alternate-day use of 600 IU of natural-source vitamin E had no large beneficial or harmful effect on risk of AMD. Copyright 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153900      PMCID: PMC2881167          DOI: 10.1016/j.ophtha.2009.10.043

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  37 in total

1.  Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study.

Authors:  G M VandenLangenberg; J A Mares-Perlman; R Klein; B E Klein; W E Brady; M Palta
Journal:  Am J Epidemiol       Date:  1998-07-15       Impact factor: 4.897

2.  Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.

Authors:  I-Min Lee; Nancy R Cook; J Michael Gaziano; David Gordon; Paul M Ridker; Joann E Manson; Charles H Hennekens; Julie E Buring
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

3.  Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.

Authors:  Nancy R Cook; I-Min Lee; J Michael Gaziano; David Gordon; Paul M Ridker; JoAnn E Manson; Charles H Hennekens; Julie E Buring
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

4.  Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy.

Authors:  J M Teikari; L Laatikainen; J Virtamo; J Haukka; M Rautalahti; K Liesto; D Albanes; P Taylor; O P Heinonen
Journal:  Acta Ophthalmol Scand       Date:  1998-04

5.  A simplified severity scale for age-related macular degeneration: AREDS Report No. 18.

Authors:  Frederick L Ferris; Matthew D Davis; Traci E Clemons; Li-Yin Lee; Emily Y Chew; Anne S Lindblad; Roy C Milton; Susan B Bressler; Ronald Klein
Journal:  Arch Ophthalmol       Date:  2005-11

6.  Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study.

Authors:  Stephan Michels; Philip J Rosenfeld; Carmen A Puliafito; Erin N Marcus; Anna S Venkatraman
Journal:  Ophthalmology       Date:  2005-06       Impact factor: 12.079

7.  Dietary intake of antioxidants and risk of age-related macular degeneration.

Authors:  Redmer van Leeuwen; Sharmila Boekhoorn; Johannes R Vingerling; Jacqueline C M Witteman; Caroline C W Klaver; Albert Hofman; Paulus T V M de Jong
Journal:  JAMA       Date:  2005-12-28       Impact factor: 56.272

8.  Pegaptanib for neovascular age-related macular degeneration.

Authors:  Evangelos S Gragoudas; Anthony P Adamis; Emmett T Cunningham; Matthew Feinsod; David R Guyer
Journal:  N Engl J Med       Date:  2004-12-30       Impact factor: 91.245

Review 9.  Visual function and dysfunction in early and late age-related maculopathy.

Authors:  R E Hogg; U Chakravarthy
Journal:  Prog Retin Eye Res       Date:  2006-03-31       Impact factor: 21.198

10.  A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Authors:  Paul M Ridker; Nancy R Cook; I-Min Lee; David Gordon; J Michael Gaziano; Joann E Manson; Charles H Hennekens; Julie E Buring
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

View more
  9 in total

1.  Vitamins E and C and medical record-confirmed age-related macular degeneration in a randomized trial of male physicians.

Authors:  William G Christen; Robert J Glynn; Howard D Sesso; Tobias Kurth; Jean Macfadyen; Vadim Bubes; Julie E Buring; Joann E Manson; J Michael Gaziano
Journal:  Ophthalmology       Date:  2012-04-13       Impact factor: 12.079

Review 2.  Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.

Authors:  Jennifer R Evans; John G Lawrenson
Journal:  Cochrane Database Syst Rev       Date:  2017-07-30

Review 3.  Nutritional modulation of age-related macular degeneration.

Authors:  Karen A Weikel; Chung-Jung Chiu; Allen Taylor
Journal:  Mol Aspects Med       Date:  2012-04-06

4.  Effects of multivitamin supplement on cataract and age-related macular degeneration in a randomized trial of male physicians.

Authors:  William G Christen; Robert J Glynn; Joann E Manson; Jean MacFadyen; Vadim Bubes; Miriam Schvartz; Julie E Buring; Howard D Sesso; J Michael Gaziano
Journal:  Ophthalmology       Date:  2013-11-20       Impact factor: 12.079

Review 5.  Dietary supplements and disease prevention - a global overview.

Authors:  Susanne Rautiainen; JoAnn E Manson; Alice H Lichtenstein; Howard D Sesso
Journal:  Nat Rev Endocrinol       Date:  2016-05-06       Impact factor: 43.330

6.  The association between blood vitamins D and E with age-related macular degeneration: A pilot study.

Authors:  Rezvan Hashemi; Mahin Bandarian; Elahe Abedi-Taleb; Hassan Khojasteh; Leila Khedmat; Elnaz Asadollahi; Mina Beytollahi; Asghar Mollazadeh Jelodar
Journal:  Interv Med Appl Sci       Date:  2018-09

Review 7.  Central Role of Oxidative Stress in Age-Related Macular Degeneration: Evidence from a Review of the Molecular Mechanisms and Animal Models.

Authors:  Samuel Abokyi; Chi-Ho To; Tim T Lam; Dennis Y Tse
Journal:  Oxid Med Cell Longev       Date:  2020-02-10       Impact factor: 6.543

Review 8.  Implication of Dietary Iron-Chelating Bioactive Compounds in Molecular Mechanisms of Oxidative Stress-Induced Cell Ageing.

Authors:  Alexandra Barbouti; Nefeli Lagopati; Dimitris Veroutis; Vlasios Goulas; Konstantinos Evangelou; Panagiotis Kanavaros; Vassilis G Gorgoulis; Dimitrios Galaris
Journal:  Antioxidants (Basel)       Date:  2021-03-21

9.  Effect of Vitamin D and ω-3 Fatty Acid Supplementation on Risk of Age-Related Macular Degeneration: An Ancillary Study of the VITAL Randomized Clinical Trial.

Authors:  William G Christen; Nancy R Cook; JoAnn E Manson; Julie E Buring; Daniel I Chasman; I-Min Lee; Vadim Bubes; Chunying Li; Margarette Haubourg; Debra A Schaumberg
Journal:  JAMA Ophthalmol       Date:  2020-12-01       Impact factor: 7.389

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.